HODGKIN'S LYMPHOMA

Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new HODGKIN'S LYMPHOMA trials appear

Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 3 Completed 4

New drug aims to stop deadly transplant complication

Disease control Not yet recruiting

This study tests a drug called ivarmacitinib to prevent acute graft-versus-host disease (aGVHD) in 32 people with blood cancers receiving a half-matched stem cell transplant. The goal is to see if the drug can lower the chance of severe GVHD and improve survival without long-term…

Matched conditions: HODGKIN'S LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Jun 27, 2026 09:01 UTC

HODGKIN'S LYMPHOMA

Get alerted when new HODGKIN'S LYMPHOMA trials appear

New drug aims to stop deadly transplant complication